Literature DB >> 30123550

Multi-analyte assays and early detection of common cancers.

Robert P Young1, Timothy Christmas2, Raewyn J Hopkins1.   

Abstract

Entities:  

Year:  2018        PMID： 30123550      PMCID： PMC6072951          DOI： 10.21037/jtd.2018.06.58

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  19 in total

1.  In search of the holy grail: lung cancer biomarkers.

Authors:  Douglas Arenberg
Journal:  Chest       Date:  2004-08       Impact factor: 9.410

2.  Sequencing of Tumor DNA to Guide Cancer Risk Assessment and Therapy.

Authors:  David H Spencer; Timothy J Ley
Journal:  JAMA       Date:  2018-04-10       Impact factor: 56.272

Review 3.  Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.

Authors:  Jason D Merker; Geoffrey R Oxnard; Carolyn Compton; Maximilian Diehn; Patricia Hurley; Alexander J Lazar; Neal Lindeman; Christina M Lockwood; Alex J Rai; Richard L Schilsky; Apostolia M Tsimberidou; Patricia Vasalos; Brooke L Billman; Thomas K Oliver; Suanna S Bruinooge; Daniel F Hayes; Nicholas C Turner
Journal:  J Clin Oncol       Date:  2018-03-05       Impact factor: 44.544

Review 4.  Intra-tumour heterogeneity: a looking glass for cancer?

Authors:  Andriy Marusyk; Vanessa Almendro; Kornelia Polyak
Journal:  Nat Rev Cancer       Date:  2012-04-19       Impact factor: 60.716

5.  Detection of circulating tumor DNA in early- and late-stage human malignancies.

Authors:  Chetan Bettegowda; Mark Sausen; Rebecca J Leary; Isaac Kinde; Yuxuan Wang; Nishant Agrawal; Bjarne R Bartlett; Hao Wang; Brandon Luber; Rhoda M Alani; Emmanuel S Antonarakis; Nilofer S Azad; Alberto Bardelli; Henry Brem; John L Cameron; Clarence C Lee; Leslie A Fecher; Gary L Gallia; Peter Gibbs; Dung Le; Robert L Giuntoli; Michael Goggins; Michael D Hogarty; Matthias Holdhoff; Seung-Mo Hong; Yuchen Jiao; Hartmut H Juhl; Jenny J Kim; Giulia Siravegna; Daniel A Laheru; Calogero Lauricella; Michael Lim; Evan J Lipson; Suely Kazue Nagahashi Marie; George J Netto; Kelly S Oliner; Alessandro Olivi; Louise Olsson; Gregory J Riggins; Andrea Sartore-Bianchi; Kerstin Schmidt; le-Ming Shih; Sueli Mieko Oba-Shinjo; Salvatore Siena; Dan Theodorescu; Jeanne Tie; Timothy T Harkins; Silvio Veronese; Tian-Li Wang; Jon D Weingart; Christopher L Wolfgang; Laura D Wood; Dongmei Xing; Ralph H Hruban; Jian Wu; Peter J Allen; C Max Schmidt; Michael A Choti; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos; Luis A Diaz
Journal:  Sci Transl Med       Date:  2014-02-19       Impact factor: 17.956

6.  Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy Statement.

Authors:  Peter J Mazzone; Catherine Rufatto Sears; Doug A Arenberg; Mina Gaga; Michael K Gould; Pierre P Massion; Vish S Nair; Charles A Powell; Gerard A Silvestri; Anil Vachani; Renda Soylemez Wiener
Journal:  Am J Respir Crit Care Med       Date:  2017-10-01       Impact factor: 21.405

7.  Validation of a multiprotein plasma classifier to identify benign lung nodules.

Authors:  Anil Vachani; Harvey I Pass; William N Rom; David E Midthun; Eric S Edell; Michel Laviolette; Xiao-Jun Li; Pui-Yee Fong; Stephen W Hunsucker; Clive Hayward; Peter J Mazzone; David K Madtes; York E Miller; Michael G Walker; Jing Shi; Paul Kearney; Kenneth C Fang; Pierre P Massion
Journal:  J Thorac Oncol       Date:  2015-04       Impact factor: 15.609

8.  Tumour heterogeneity poses a significant challenge to cancer biomarker research.

Authors:  Karolina Cyll; Elin Ersvær; Ljiljana Vlatkovic; Manohar Pradhan; Wanja Kildal; Marte Avranden Kjær; Andreas Kleppe; Tarjei S Hveem; Birgitte Carlsen; Silje Gill; Sven Löffeler; Erik Skaaheim Haug; Håkon Wæhre; Prasanna Sooriakumaran; Håvard E Danielsen
Journal:  Br J Cancer       Date:  2017-06-15       Impact factor: 7.640

9.  GSTM1 null genotype in COPD and lung cancer: evidence of a modifier or confounding effect?

Authors:  Robert P Young; Raewyn J Hopkins; Bryan A Hay; Gregory D Gamble
Journal:  Appl Clin Genet       Date:  2011-09-13

Review 10.  Building the Evidence Base of Blood-Based Biomarkers for Early Detection of Cancer: A Rapid Systematic Mapping Review.

Authors:  Lesley Uttley; Becky L Whiteman; Helen Buckley Woods; Susan Harnan; Sian Taylor Philips; Ian A Cree
Journal:  EBioMedicine       Date:  2016-07-06       Impact factor: 8.143
View more
  3 in total

1.  Identification of a Blood-Based Protein Biomarker Panel for Lung Cancer Detection.

Authors:  Victoria El-Khoury; Anna Schritz; Sang-Yoon Kim; Antoine Lesur; Katriina Sertamo; François Bernardin; Konstantinos Petritis; Patrick Pirrotte; Cheryl Selinsky; Jeffrey R Whiteaker; Haizhen Zhang; Jacob J Kennedy; Chenwei Lin; Lik Wee Lee; Ping Yan; Nhan L Tran; Landon J Inge; Khaled Chalabi; Georges Decker; Rolf Bjerkvig; Amanda G Paulovich; Guy Berchem; Yeoun Jin Kim
Journal:  Cancers (Basel)       Date:  2020-06-19       Impact factor: 6.639

2.  Management of incidental nodules in lung cancer screening: ready for prime-time?

Authors:  Nikolaos I Kanellakis; Kevin Lamote
Journal:  Breathe (Sheff)       Date:  2019-12

Review 3.  Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic Cancer.

Authors:  Jedrzej J Jaworski; Robert D Morgan; Shivan Sivakumar
Journal:  Cancers (Basel)       Date:  2020-12-09       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.